$GOVX has been mentioned 7 times over the past 12 months by 2 distinct FinTwit voices, with @investmentguru_ accounting for 5 mentions and @acinvestorblog for 2 mentions. The first mention appeared on 2026-05-18, and the most recent on 2026-06-25. The discussion category has centered on long research, with @investmentguru_ characterizing $GOVX as a biotech vaccine and immunology play that moved from $1.01 on April 30 to above $4.30 by May 18 before pulling back to the $2 area, noting Ebola-related developments as a potential catalyst.